GLP-1: a mediator of the beneficial metabolic effects of bariatric surgery? - Wikidata - awgldk - TriplyDB

GLP-1: a mediator of the beneficial metabolic effects of bariatric surgery?

GLP-1: a mediator of the beneficial metabolic effects of bariatric surgery?

http://www.wikidata.org/entity/Q38307449

about

Increasing GLP-1 Circulating Levels by Bariatric Surgery or by GLP-1 Receptor Agonists Therapy: Why Are the Clinical Consequences so Different?Anti-ghrelin antibodies in appetite suppression: recent advances in obesity pharmacotherapy PPG neurons of the lower brain stem and their role in brain GLP-1 receptor activation.Gastrointestinal dopamine as an anti-incretin and its possible role in bypass surgery as therapy for type 2 diabetes with associated obesity.Cardiovascular Benefits of Native GLP-1 and its Metabolites: An Indicator for GLP-1-Therapy Strategies.Integrative and adaptive responses.Predictors of Long-Term Remission and Relapse of Type 2 Diabetes Mellitus Following Gastric Bypass in Severely Obese Patients.The impact of bariatric surgery on inflammation: quenching the fire of obesity?Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.Biological control of appetite: A daunting complexity.Mechanisms of Diabetes Improvement Following Bariatric/Metabolic Surgery.

P2860

Q26744254-85B4D24E-F057-47B8-BEC8-FAA4EEDECFF7 Q27023771-3E57AC7C-E569-4F52-86E9-ABC6952D7F9A Q36339320-BDAE512F-D9DD-4BA7-8AED-9B98281A0C01 Q37365588-D7904713-5CB1-4B14-916B-4D5D72D9246C Q37611715-7A6981BB-7990-472D-AD67-82DAAD6887CE Q38307440-025679E1-1A0A-4D97-AC81-75F98A71CD57 Q38645171-3F95C18E-1AE7-40A3-A743-6E3D760687B3 Q38838093-6A258615-ECDB-4CFE-B157-0D024A10DDEA Q39047697-C7E4D05D-8A24-470B-8672-103CF2F47492 Q39147573-A7816650-F137-47A6-BB06-C2086B753E5A Q53784109-4F7B1CC8-E6FA-40B4-B5E2-6357AFF840C7

P2860

GLP-1: a mediator of the beneficial metabolic effects of bariatric surgery?

http://www.wikidata.org/entity/Q38307449

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

GLP-1: a mediator of the beneficial metabolic effects of bariatric surgery?

@en

type

label

GLP-1: a mediator of the beneficial metabolic effects of bariatric surgery?

@en

prefLabel

GLP-1: a mediator of the beneficial metabolic effects of bariatric surgery?

@en

P1433

Q38307449-CEBF65C4-4A84-4A9B-897E-271CBEDCA388

P1476

Q38307449-1EAA539D-8501-43FF-AA62-329B5ACD1D35

P2093

Q38307449-001049EF-3C75-4BB8-A5DA-DA32B620DFBD

Q38307449-95265197-89C6-46C6-92AB-7C578E7B5BF1

Q38307449-C72D3F29-85EC-4403-A934-C9977A881381

P2860

Q38307449-03CE2950-2A19-4152-A03A-1E7F91E0E983

Q38307449-04E82FDA-123D-4343-AE2F-5D7E79E4F4C8

Q38307449-09EBCB09-8403-414A-8DFC-942EF6BB27AC

Q38307449-0CA8001B-BA5E-45BA-9A43-C4F412374362

Q38307449-0D39D5F7-37A9-44B1-8A51-11F2F2AA7661

Q38307449-0D7ED2CE-0863-403E-8906-C45E40BD301B

Q38307449-0E777507-4920-4555-AC0D-B3155457DB44

Q38307449-10104424-9FB5-4CD4-AA44-D3207F3D6C51

Q38307449-103A6C40-7914-4A39-A093-9E8318B39699

Q38307449-11C41E26-F6E0-4323-917B-C3A70FD704CD

P304

Q38307449-0CF41C80-FD80-4E8B-B1CA-ED0629B5700E

P31

Q38307449-1291DC92-DBD2-48DB-A1BD-4E1AC7E38AFA

P356

Q38307449-8D61B4A0-6AC0-4283-99F2-F4D650B4489F

P433

Q38307449-E7E4013D-67B4-4742-970B-FCE03EB4CA71

P478

Q38307449-A2FC647C-E82B-4BCC-9452-F38176CCEC6F

P577

Q38307449-D67F0EB9-DCFF-41CA-BC62-8E099A53E251

P5875

Q38307449-AC9D80B0-924E-40BB-BF48-69B8BAD8B3F9

P698

Q38307449-67D44B2B-E765-4744-A407-D277850C08A2

P921

Q38307449-8C1C5B26-ED66-439E-AD8C-CF6BF2BD8336

P356

PHYSIOL.00027.2014

P1433

P1476

GLP-1: a mediator of the beneficial metabolic effects of bariatric surgery?

@en

P2093

Andrea Pucci

http://www.w3.org/2001/XMLSchema#string

Rachel L Batterham

http://www.w3.org/2001/XMLSchema#string

Sean Manning

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects

A role for glucagon-like peptide-1 in the central regulation of feeding

The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control

Enhanced Intestinal Motility during Oral Glucose Tolerance Test after Laparoscopic Sleeve Gastrectomy: Preliminary Results Using Cine Magnetic Resonance Imaging

Gut peptides in the regulation of food intake and energy homeostasis

Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones

The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.

Altered islet function and insulin clearance cause hyperinsulinemia in gastric bypass patients with symptoms of postprandial hypoglycemia

Could the mechanisms of bariatric surgery hold the key for novel therapies? report from a Pennington Scientific Symposium.

Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes

P304

50-62

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/PHYSIOL.00027.2014

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

270652601

http://www.w3.org/2001/XMLSchema#string

P698

25559155

http://www.w3.org/2001/XMLSchema#string

P921

bariatric surgery